Navigation Links
Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter
Date:5/13/2009

Telesso Technologies Limited (ASX: TEO), a global healthcare company, announced today the FDA-approved guide wire-assisted peripheral IV catheter it is developing with Vascular Pathways, Inc., has been honored with the Popular Science Invention Award.

"Telesso is pleased to receive another exciting external validation of this innovative device that may revolutionize peripheral IV placement," said Telesso's CEO Nelson K. Stacks. "Attempts to start an IV frequently fail, which is frustrating for clinicians, painful for patients and costly to the health care system. The new guide-wire assisted peripheral IV catheter uses a practical design to improve the ability for clinicians to get it right the first time, creating efficiency, enhancing safety, reducing costs, and avoiding the need for re-sticks."

A post-market trial is currently comparing patients treated with Telesso's catheter to the industry's gold standard device for peripheral IV placement. Data review is expected in Q2-Q3 2009.

About the Guide Wire-Assisted Peripheral IV Catheter

A peripheral vein is the most common site for insertion of a catheter for short-term diagnostic or therapeutic use. The catheter is placed into the peripheral vein in the arm and is typically passed up inside the vein to a length of 2-3 inches. Telesso's uniquely-designed guide wire-assisted peripheral IV catheter device uses a first-in-class retractable nitinol guide wire system that is believed to enable easier IV access, reduce common safety risks, significantly lessen patient pain and discomfort, and provide cost savings to facilities by lowering administrative costs associated with failed IV starts. Telesso believes this catheter device is the first clinically meaningful advancement in peripheral IV access since automatic needle retraction catheters and addresses significant unmet needs in peripheral intravenous access.


'/>"/>

Contact: Jeff Riley
riley@telesso.com
619-309-7661
Cytori Therapeutics
Source:Eurekalert

Page: 1

Related medicine news :

1. Telesso initiates post-market head-to-head peripheral IV catheter study
2. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
3. MedClean Technologies, Inc. Approved in New Jersey
4. The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors
5. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
6. Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
7. Steven H. Kane Appointed as President and Chief Executive Officer of Patient Safety Technologies, Inc.
8. Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009
9. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
10. Greenway Medical Technologies PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care
11. Top 10 Hospital Technologies: C-Suite Watch List for 2009 and Beyond; Exclusive Insight on Critical Capital Decisions in ECRI Institute White Paper Available for Free Download
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... ... Park Cities Pet Sitter President, Joette White, has been featured on Episode ... The episode, which was posted this week, features a 30-minute interview of White by ... Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business of ...
(Date:2/17/2017)... ... February 17, 2017 , ... The ... systems change designed to further positively impact the health and wellness of our ... long considered it our duty to seriously consider releasing our assets beyond our ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — ... Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's 8th ... of clinical trial planning and management. Pharmica discussed the importance of effective project ... attendees stopping by Pharmica’s booth were able to demo its cloud-based Resource ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Research and Markets has announced the addition of ... to their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... AMSTERDAM , Feb. 17, ... connected health offerings at the  ...  (NYSE: PHG,AEX: PHIA), a global ... a broad range of population ... personal health solutions, fully integrated in a ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
Breaking Medicine Technology: